Comparing Buprenorphine Treatment Outcomes Among Kentucky Medicaid Patients by Prescriber Specialty and Type

Green VR, Bandara S, Sugarman OK, Gibbons JB, Saloner B, Heidari O - Substance Use & Misuse

  • Regulation and Clinical Evidence

Summary:

Among Kentucky Medicaid patients treated for opioid use disorder, those who received most of their buprenorphine from primary care physicians stayed on treatment longest (covered 69.6% of days vs. 60.1% for specialists and 64.3% for advanced practice providers), while patients of advanced practice providers had the lowest rate of non-fatal overdose. The results suggest that several types of providers can effectively prescribe buprenorphine, supporting efforts to expand who can deliver this treatment.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
An icon of a bill representing government policy.

Comments on FDA Discussion Paper, “Considerations for the Regulation of Generative AI-Enabled Medical Devices”

Jaiswal N, Gorijavolu R, Thomas S, Hwang TJ, Celi LA, Kesselheim AS - Food and Drug Administration (FDA)

  • Regulation and Clinical Evidence